Web Analytics Made Easy - StatCounter

Vincristine Inj Tenders

Get complete information related to latest Vincristine Inj Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Vincristine Inj Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Vincristine Inj Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

CTN :45642339 Due date: 01 Aug, 202601 Aug, 2026 20.00 Crore
Tender For procurement of d m - levamisole hcl i.p 75 mg/ml inj., ivermectin i.p 3.1 percent inj., quinapyramine sulphate bp 2 g, quinapyramine prosalt (quinapyramine sulphate b.p 1.5 gm plus quinapyramine chloride b.p 1 gm), each ml containsclosantel 50 mg,benzyl alcohol ip 4percent v/v (as preservative), propylene glycol ip q.s., each ml containsclosantel 50 mg,benzyl alcohol ip 4percent v/v (as preservative), propylene glycol ip q.s., each ml contains ivermectin i.p. 0.9 percent w/v, benzyl alchohol i.p.( as a preservative), each uncoated tablet contains niclosamide piperazine salt 1250 mg excipients qs., albendazole i.p 3 gm/bolus, oxfendazole b.p 2.265 percent w/v suspension, piperzine hexahydrate- 45 percent w/v plus levamisole hydrochloride i.p- 1.5 percent w/v solution, closantel i.p 6 gm/bolus, each uncoated bolus containstriclabendazole- 4 g, fenbendazole- i.p 2 g, each ml contains precipitated sulphur usp 2 mg, benzyl benzoate i.p 0.1 g, lidocaine hcl i.p 2 percent w/v inj, each uncoated tablet containsoxfendazole i.p-375 mg, pyrantel embonate i.p-500 mg, antimony potassium tartrate 2 percent, niclosamide 10percent and levamisole hcl i.p 1.5percent suspension, ampicillin sodium i.p equivalent to anhydrous ampicillin 2 gm plus sterile sulbactam sodium i.p equivalent to anhydrous sulbactam 1 gm, ceftiofur sodium i.p 250 mg inj., procaine penicillin i.p 24 lakh plus penicillin-g sodium 12 lakh plus benzathine penicillin 12 lakh inj., each vial contains sterile ceftiofur soduim i.p eq to anhydrous ceftiofur 1.25mg , each vial (part b) per ml contains n-methyl 2-pyrrolidone 300mg ,benzyl alcohol i.p 10mg ,aqueous base q.s, oxytetracycline hcl ip 120 mg, propylene glycol ip q.s, ceftizoxime ip 3 grams, cefotaxime sodium i.p 500mg inj., ofloxacin ip 10 percent w/ v omidazole ip12 percent w/v, each bolus contains ofloxacin 1000mg,cefixime 1000mg, lactic acid bacillus 120 million spores, each bolus contains halquinol i.p 1.5 gm, each bolus contains ofloxacin 900mg,tindazole 2700mg , dicyclomin 50mg,dimethicon 75mg, enrofloxacin ip 100 mg, ambroxol hydrochloride ip 7.5 mg/ml inj, enrofloxacin i.p 100 mg/ml (long acting) inj., each vail contains enrofloxacin ip (vet) 500mg plus zinc 50mg ( as zinc acetate usp)plus pefloxacin mesilate bp 1500mg ( one ffs ampoule containing swfi ip 20ml ), cefoperazone sodium ip eq to anhydrous cefoperazone 2 gm plus sulbactam sodium usp equivalent to anhydrous sulbactam 1.0 gm, each 4500 mg vial contains cefoperazone sodium ip 3000 mg plus sulbactum sodium usp 1500 mg, trimethoprim i.p 40 mg plus sulphadoxine i.p 200 mg/ml inj., streptomycin sulphate i.p equivalent to 5 g base plus procaine penicillin i.p 30 lakh units plus penicillin g sodium i.p 10 lakh units inj., ofloxacin oral solution ip 10 percent w/v, neomycin sulphate b.p (vet) 5 mg, bacitracin b.p vet 500 i.u cream, gentamicin 0.3 percent w/v , i.p eye drops, each gm contains sulphachlorpyridazine sodium 100mg , trimethoprim ip 20mg, one glass vial contains amoxycillin sodium ip(sterile) equivalent to anhydrous amoxyxillin 3000mg pluspotassium clavulanate ip(sterile) equivalent to clavulanic acid 600mg, streptomycin sulphate 100 mg plus procaine penicillin 1 lakh i.u plus sulphamerazine 500 mg plus hydro cortisone acetate 20 mg, each ml contains levofloxacin hemihydrate equivalent to levofloxacin ip 100 mg plus benzyl alcohol i.p 1.5 percent v/v, water for injection i.p, ofloxacin i.p 0.3 percent , benzalkonium chloride i.p 0.02 percent , ear/eye drops, each 8 g syringe contains cefquinome as sulphate 75 mg, doxycycline 100mg, cefquinome 2.5 percent (each ml contains 25mg), miconazole nitrate ip 2.0 percent w/w plus ofloxacin ip 0.1 percent w/w plus clobetasol propionate ip 0.025 percent w/w, each 3g syringe contains 250 mg of cefalonium dihydrate, each 4 g (60ml when reconstituted as directed) contain cephalexin monohydrate ip equivalent to anhydrous cephalexin 1.5g, serratiopeptidase- 10mg, each ml contains penicillin g procaine ip 300000 unit

corporations/Associations/Others

CTN :45477028 Due date: 06 Jul, 202606 Jul, 2026 13.71 Crore
Tender For corrigendum : e-bid for rate contract cum supply and empanelment of firms for drugs and medicines - fluorouracil inj ip 250 mg/ 5ml [148], mercaptopurine tablets ip 50mg [152], methotrexate tab ip 2.5 mg [154], vincristine injection ip 1mg [159], atropine eye ointment ip 1%[319], ciprofloxacin ophthalmic ointment usp 0.3% [323], dacarbazine injection 500mg ip [529], inj. ganciclovir sodium 500mg (lyophilized powder forreconstitution) [724], recombinant f ix 500 iu with diluent [748], 3rd generation recombinant fviii 250 iuwith diluent [749], gatifloxacin 0.30% and prednisolone acetate 1% ophthalmic suspension[nrd-103], hpmc 0.3%eye drop [nrd-104], chloramphenic ol 1%, polymyxin b sulphate (10000 units) and dexamethasone 0.1% sodium phosphate eye ointment[nrd-123], cabazitaxel injection 60 mg [nrd-167], fludarabine phosphate injection 100mg inj. ip [nrd-237], fludarabine phosphate injection 50mginj. ip [nrd-238], methotrexate 1000 mg inj. ip [nrd-289], inj. methylprednisol one acetate 125 mg i.p. (each vial contains methylprednisol one acetate 125mg) [nrd-292], mitomycin 40 mg inj. ip [nrd-297], omalizumab 150 mg vial inj. [nrd-321], plerixafor 24 mg inj. [nrd-338], recombinant lh 75iu inj. [nrd-351], trabectedin 1 mg inj. [nrd-387], everolimus 5mg tab./cap. [nrd-530], everolimus 10mg tab./cap. [nrd-531], eltrombopag 25mg tablet / capsule [nrd-617], eltrombopag 50mg tablet / capsule [nrd-618], nilotinib 150 mg tablet / capsule [nrd-710], nilotinib 200 mg tablet / capsule [nrd-711], regorafenib 40 mg tab. [nrd-757], tegafur 100mg and uracil 224mg capsule[nrd-794], ulipristal 5mg tab. [nrd-808], black disinfectant fluid (phenyl) as per scheduleo grade iii [398], phenobarbitone inj ip 200mg/ml [420], piperacillin + tazobactum for injection ip 4gm+500mg[468], decitabine 50 mg inj. [nrd-207], levosalbutamol 50mcg. and ipratropium40mcg. mdi [nrd-425], glycopegylated extended half life factor viii 1000 iu

corporations/Associations/Others

CTN :44434778 Due date: 01 Jul, 202601 Jul, 2026 NA
Tender For corrigendum : supply of drugs/medicines - cyclosporine tab/cap -each tab/cap to contain: cyclosporine 50mg., 5-fluorouracil inj-each vial to contain: fluorouracil ip 250mg, cytosine arabinoside inj-each vial to contain: cytosine arabinoside 100mg, packing: 1 vial, tamoxifen tab/cap-each tab/cap to contain: tamoxifen 10mg, bleomycin inj-each vial to contain: bleomycin ip 15iu, vincristine inj-each vial to contain: vincristine ip 1mg, doxorubicin inj-each 5 ml vial to contain: doxorubicin 10mg, methotrexate tab/cap-each tab/cap to contain: methotrexate ip 2.5mg, ifosfamide inj-each vial to contain: ifosfamide 1gm, flutamide tab/cap-each tab/cap to contain: flutamide 250mg, goserelin inj-each pfs to contain: goserelin 3.6mg packing: 1 pfs, vero cell culture rabies vaccine-each dose to contain: purified vero cell culture human rabies vaccine, methotrexate inj-each vial to contain: methotrexate ip 50mg, tamoxifen tab/cap-each tab/cap to contain:tamoxifen 20mg, tetanus vaccine (adsorbed)-each 0.5 ml to contain: tetanus toxoid 5/lfs, capd bag-each bag to contain: capd bag 7.5% of lcodextrin with asymmetrical y connector packing:2 ltr bag, human albumin 20% inj-each bottle to contain: human albumin 20% packing: 100ml bottle, anastrozole tab/cap-each tab/cap to contain: anastrozole 1mg, asparaginase inj-each vial to contain: asparaginase 10000 unit, methotrexate tab/cap-each tab/cap to contain: methotrexate 7.5mg, sorafenib tab/cap-each tab/cap to contain: sorafenib tosylate 200mg, immunoglobulin-each 1 ml solution to contain: active substance (s) human plasma proteins 50 mg, igm 6 mg (12%) , iga 6 mg (12%) igg 38 mg (76%), packing:10ml vial, anti-rabies vaccine-each ml to contain: hrg (rabies immunoglobulin (human)) 150iu, packing:2ml vial/amp/pfs, mycophenolate tab/cap-each tab/cap to contain: mycophenolic acid (as sodium salt) 540mg, leucovorin inj-each vial to contain: leucovorin 50mg, lenalidomide tab/cap-each tab/cap to contain: lenalidomide 5mg, zoledronic acid inj-each vial to contain: zoledronic acid 4mg, octreotide inj-each vial to contains: octreotide 30mg long acting release packing: 1 vial, ceritinib tab/cap-each tab/ hard gelatin cap to contain: ceritinib 150mg, ruxolitinib tab/cap-each tab/cap to contains ruxolitinib 15mg, ruxolitinib tab/cap-each tab/cap contains ruxolitinib 20mg, ruxolitinib tab/cap-each tab/cap contains ruxolitinib 5mg, nivolumab inj-each vial to contain: nivolumab 40mg packing: 1 vial, nivolumab inj-each vial to contain: nivolumab 100mg packing: 1 vial, crizotinib tab/cap-each hard gelatin tab/cap to contain : crizotinib 250mg, carfilzomib inj-each vial to contain: carfilzomib 60mg sterile lypholized powder packing: 1 vial, afatinib tab/cap-each tab/cap to contain: afatinib 20 mg, afatinib tab/cap-each tab/cap to contain: afatinib 30 mg, axitinib tab/cap-each film coated tab/cap to contain: axitinib 5 mg, trabectedin inj-each vial to contain:trabectedin 1mg packing: 1 vial, afatinib tab/cap-each tab/cap to contain: afatinib 40 mg, regorafenib tab/cap-each tab/cap to contain: regorafenib 40mg, recombinant human granulocyte inj-each inj to contain: recombinant human granulocyte macrophage colony stimulating factor (r-hu-gmcsf) 500microgram, degarelix inj-each vial to contain: degarelix 80 mg packing: 1 vial, erlotinib tab/cap-each tab/cap to contain: erlotinib 150 mg, everolimus tab/cap-each tab/cap to contains: everolimus 5 mg, secukinumab inj-each 1 ml to conatin: secukinumab 150mg, sucrose 92.43mg, l- histidine / l- histidine hcl monohydrate 4.656 mg, polysorbate 80 - 0.60mg.packing: 1 vial, tenofovir alafenamide tab/cap-each tab/cap to contains: tenofovir alafenamide 25mg, meningococcal vaccine-each vial to contain: meningococcal group (a,c,y and w135)polysachharide/oligosaccharide diphtheria toxoid conjugate vaccine,0.5 ml vial/pfs, lenvatinib tab/cap-each tab/cap to contains: lenvatinib 4mg, lenvatinib tab/cap-each tab/cap to contains: lenvatinib 10mg, ribociclib tab/cap-each film coated tab/cap

corporations/Associations/Others

CTN :45087762 Due date: 19 May, 202619 May, 2026 8.46 Crore
Tender For short term e-bid for rate contract cum supply and empanelment of firms for drugs and medicines - fluorouracil inj ip 250 mg/ 5ml [148], mercaptopurine tablets ip 50 mg [152], methotrexate tab ip 2.5 mg [154], vincristine injection ip 1 mg [159], atropine eye ointment ip 1% [319], ciprofloxacin ophthalmic ointment usp 0.3% [323], dacarbazine injection 500 mg ip [529], inj. ganciclovir sodium 500mg (lyophilized powder for reconstitution) [724], recombinant f ix 500 iu with diluent [748], 3rd generation recombinant f viii 250 iu with diluent [749], brinozolamide 1% w/v and brimonidine tartrate 0.2% w/v ophthalmic suspension [nrd-98], gatifloxacin 0.30% and prednisolone acetate 1% ophthalmic suspension [nrd-103], hpmc 0.3% eye drop [nrd-104], proparacaine 0.5% w/v eye drop usp [nrd-114], voriconazole 1 % w/v (lyophilized) 30mg eye drop [nrd-119], chloramphenicol 1%, polymyxin b sulphate (10000 units) and dexamethasone 0.1% sodium phosphate eye ointment [nrd-123], cabazitaxel injection 60 mg [nrd-167], carmustine 100 mg inj. ip [nrd-175], fludarabine phosphate injection 100mg inj. ip [nrd-237], fludarabine phosphate injection 50mg inj. ip [nrd-238], methotrexate 1000 mg inj. ip [nrd-289], inj. methylprednisolone acetate 125 mg i.p. (each vial contains methylprednisolone acetate 125 mg) [nrd-292], mitomycin 40 mg inj. ip [nrd-297], omalizumab 150 mg vial inj. [nrd-321], plerixafor 24 mg inj. [nrd-338], rasburicase 1.5 mg inj. [nrd-347], recombinant lh 75iu inj. [nrd-351], trabectedin 1 mg inj. [nrd- 387], everolimus 5mg tab./cap. [nrd-530], everolimus 10mg tab./cap. [nrd-531], eltrombopag 25mg tablet / capsule [nrd-617], eltrombopag 50mg tablet / capsule [nrd-618], nilotinib 150 mg tablet / capsule [nrd-710], nilotinib 200 mg tablet / capsule [nrd-711], regorafenib 40 mg tab. [nrd-757], tegafur 100mg and uracil 224mg capsule [nrd-794], ulipristal 5mg tab. [nrd-808], glycopegylated extended half life factor viii 1000 iu
 Loading, Please wait...

Connect us via What's Up